From SBA 7(a) loans to seller carry structures, understand the capital stack options available when buying a licensed residential treatment center in the $1M–$5M revenue range.
Acquiring a licensed residential behavioral health facility requires financing strategies that account for regulatory complexity, license transferability, payer contract continuity, and workforce retention. Lenders familiar with healthcare services will evaluate EBITDA, occupancy stability, payer mix, and accreditation status. Most lower middle market deals combine two or three capital sources into a structured stack.
The most accessible path for individual operators and small PE-backed buyers acquiring licensed behavioral health facilities. SBA 7(a) loans cover goodwill, working capital, and equipment up to $5M, making them well-suited for residential treatment center acquisitions.
Pros
Cons
Regional banks and healthcare-focused lenders such as Live Oak Bank or BMO Harris offer conventional term loans for behavioral health acquisitions, typically requiring stronger borrower financials and larger equity contributions than SBA programs.
Pros
Cons
Common in behavioral health residential deals, seller carry of 10%–20% of purchase price bridges valuation gaps and aligns seller incentives during license transfer, census stabilization, and referral network transition periods of 12–24 months.
Pros
Cons
$3,200,000 (4x EBITDA on $800K EBITDA residential dual diagnosis facility, 85% occupancy, CARF accredited)
Purchase Price
Approximately $28,500/month combined debt service on SBA note at 10.5% over 10 years plus seller note interest-only at 7%
Monthly Service
Estimated DSCR of 1.35x based on $800K EBITDA and $342,000 annual debt service, meeting typical lender minimum of 1.25x
DSCR
SBA 7(a) senior loan: $2,560,000 (80%) | Seller carry note subordinated: $480,000 (15%) | Buyer equity/down payment: $160,000 (5%)
Yes. Licensed residential behavioral health and addiction treatment facilities are generally SBA-eligible businesses. Lenders will verify that the facility holds valid state licensure, maintains accreditation, and has a documented revenue history with diversified payer sources.
License transfer timelines vary by state, ranging from 30 to 180 days post-close. Experienced SBA and conventional lenders structure closings with license transfer as a post-closing covenant rather than a condition precedent, avoiding deal delays while protecting lender and buyer.
Lower middle market behavioral health residential facilities typically trade at 4x–7x EBITDA. CARF accreditation, stable occupancy above 75%, diversified payer mix, and experienced retained clinical leadership support valuations at the higher end of that range.
Yes, with conditions. SBA guidelines allow seller notes but require full subordination to the SBA lender with no payments during the loan term in most cases. The seller note typically counts toward the equity injection requirement when properly structured.
More Behavioral Health Residential Guides
DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers